A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients

Completed

Conditions studied: Vitamin D Deficiency, End Stage Renal Disease

In brief

Hypothesis: 25-hydroxy vitamin D levels in non-itching hemodialysis (HD) patients will be higher than those in HD patients with itching 25-hydroxy vitamin D levels will be measured in non-itching hemodialysis patients and compared to levels previously measured in a previous study of 25-hydroxy vitamin D levels of patients complaining of itching.

Key facts

Study ID

NCT01548716

Run by

Winthrop University Hospital

People needed

50

Starts

2011-09-01

Expected to finish

2012-02-01

Last updated by the study team

2012-03-08

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hemodialysis treatment for > 3 months No complaints of itching within 1 month prior to study enrollment

You may not qualify if…

• Age < 18 years
• Failure to provide informed consent
• Intact PTH < 70 pg/ml or > 1,000 pg/ml
• Serum phosphorus > 7.0
• Serum calcium (adjusted for albumin)> 11
• Active malignancy
• Likelihood of imminent renal transplantation
• Current ergocalciferol treatment

Where it is running

• Winthrop University Hospital Dialysis Unit — Mineola, New York, United States
• Winthrop University Hospital — Mineola, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.